{"organizations": [], "uuid": "ade335aa05e898ca1c03e918dd5ac99bef234e19", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/public/resources/images/BN-KD979_0904_c_G_20150904125501.jpg", "site_section": "http://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "http://www.wsj.com/articles/why-biogen-needs-a-growth-spurt-1445455438", "country": "", "title": "Why Biogen Needs a Growth Spurt", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "Why Biogen Needs a Growth Spurt - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-10-21T23:23:00.000+03:00", "replies_count": 0, "uuid": "ade335aa05e898ca1c03e918dd5ac99bef234e19"}, "author": "Charley Grant", "url": "http://www.wsj.com/articles/why-biogen-needs-a-growth-spurt-1445455438", "ord_in_thread": 0, "title": "Why Biogen Needs a Growth Spurt", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Cost-cutting and stock buybacks can only get Biogen so far. To reverse the sharp slide in its stock, the company needs to jump-start growth.\nBiogen on Wednesday reported third-quarter revenue of $2.8 billion and adjusted earnings per share of $4.48. Both topped analyst estimates and the latter was helped along by share repurchases. The biotech company also raised its full-year earnings guidance, in part due to its announcement that... ", "external_links": [], "published": "2015-10-21T23:23:00.000+03:00", "crawled": "2015-10-21T23:00:58.317+03:00", "highlightTitle": ""}